42CiX Biopharma42C info
$0.02info0.00%24h
Global rank29439
Market cap$13.00M
Change 7d0.00%
YTD Performance-48.89%
SP500 benchmarkUnderperform
P/E0
P/S2.98
Revenue$4.36M
Earnings-$7.09M
Dividend yield-
Main Sector
Healthcare

iX Biopharma (42C) Total Liabilities

42C Total Liabilities in 2022: $6.70M

According to iX Biopharma latest financial reports the total liabilities of 42C is $6.70M, an increase of 3.45% to 2022. At the end of 2022 company had $6.47M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that iX Biopharma is responsible for during its operational activities.

iX Biopharma (42C) Total Liabilities History from 2023 to 2022

-
Value:-

42C Total Liabilities by year

YearTotal liabilitiesChange
2023$6.70M3.45%
2022$6.47M22.77%
2021$5.27M4.87%
2020$5.03M58.58%
2019$3.17M-

View the Top Total Liabilies Stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org